Testing a new drug for type 2 diabetes when metformin and dapagliflozin aren't enough
Part of Hormones & metabolism clinical trials.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have type 2 diabetes.
- Your HbA1c (average blood sugar over 3 months) is between 7.0% and 10.0%.
- You have been taking metformin (at least 1000 mg per day) and dapagliflozin (10 mg per day) for at least 8 weeks without changing the dose.
- Your body mass index (BMI) is between 20 and 45.
- You are willing to follow the recommended diet and exercise plan during the trial.
- You do not have serious diabetes complications, certain medical histories (like severe hypoglycemia, pancreatitis, or thyroid cancer), or other conditions that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
This study tests a new medicine called HS-20094 for people with type 2 diabetes. It aims to see if it helps lower blood sugar and may also help with weight. You may be able to join if you are currently on metformin or metformin plus an SGLT-2 inhibitor.
This study tests a new medicine called HMS1005 in people with type 2 diabetes. Researchers want to see how safe it is and how the body responds to different doses. You may qualify if you have type 2 diabetes that is either untreated or controlled with common diabetes medications.
This study tests a new medicine called HP-211 in people with early-stage type 2 diabetes to see if it's safe and helps control blood sugar. You'd take the study drug along with your current diabetes management.
This study tests an investigational drug called HS-20094 to see how well it controls blood sugar in people with type 2 diabetes. It may help you manage your diabetes better if diet and exercise alone are not enough.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.